Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to -$20.0 million.

  • Eastman Chemical's Gains from Investment Securities changed N/A to -$20.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$25.0 million, marking a year-over-year decrease of 3888.89%. This contributed to the annual value of -$25.0 million for FY2025, which is 3888.89% down from last year.
  • Eastman Chemical's Gains from Investment Securities amounted to -$20.0 million in Q4 2025.
  • Eastman Chemical's Gains from Investment Securities' 5-year high stood at $19.0 million during Q1 2023, with a 5-year trough of -$30.0 million in Q3 2023.
  • Over the past 5 years, Eastman Chemical's median Gains from Investment Securities value was -$1.0 million (recorded in 2021), while the average stood at -$3.6 million.
  • Examining YoY changes over the last 5 years, Eastman Chemical's Gains from Investment Securities showed a top increase of 120000.0% in 2022 and a maximum decrease of 85000.0% in 2022.
  • Eastman Chemical's Gains from Investment Securities (Quarter) stood at $1.0 million in 2021, then surged by 1200.0% to $13.0 million in 2022, then tumbled by 161.54% to -$8.0 million in 2023, then plummeted by 125.0% to -$18.0 million in 2024, then dropped by 11.11% to -$20.0 million in 2025.
  • Its Gains from Investment Securities stands at -$20.0 million for Q4 2025, versus -$5.0 million for Q1 2025 and -$18.0 million for Q3 2024.